Cargando…
Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) is a multicausal disease characterized by motor neuron degeneration in the spinal cord and brain. Cell therapy may be a promising new treatment for this devastating disorder. We recently showed that a single low dose (10(6) cells) of mononuclear human...
Autores principales: | Garbuzova-Davis, Svitlana, Sanberg, Cyndy Davis, Kuzmin-Nichols, Nicole, Willing, Alison E., Gemma, Carmelina, Bickford, Paula C., Miller, Christina, Rossi, Robert, Sanberg, Paul R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429976/ https://www.ncbi.nlm.nih.gov/pubmed/18575617 http://dx.doi.org/10.1371/journal.pone.0002494 |
Ejemplares similares
-
Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2012) -
Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018) -
Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain
por: Bachstetter, Adam D, et al.
Publicado: (2008) -
Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014) -
Humoral factors in ALS patients during disease progression
por: Ehrhart, Jared, et al.
Publicado: (2015)